Dr. med. Ioannis Kapos | Hirslanden Group
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease | JACC: Cardiovascular Imaging
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease | JACC: Cardiovascular Imaging
Heart Clinic Hirslanden Zurich | Interdisciplinary Heart Team
Recordings CMR JOURNAL CLUB
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect
Dr. Steven F. Bolling, MD | Ann Arbor, MI | Thoracic Surgeon | US News Doctors
Dr. Isaac George, MD | New York, NY | Thoracic Surgeon | US News Doctors
Heart Clinic Zurich (Switzerland) | LinkedIn
Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden
Heart Valve Center Hirslanden | Heart Clinic Hirslanden Zurich
Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect
Recordings CMR JOURNAL CLUB
Recordings CMR JOURNAL CLUB
Ioannis Kapos – Medical Doctor – Heart Clinic Zurich (Switzerland) | LinkedIn
Profile | Ioannis Kapos | NEJM Resident 360
Recordings CMR JOURNAL CLUB
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease - ScienceDirect
Mareike GASTL | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU
Cardiovascular Medicine - Value of echocardiography in differentiation of acute dyspnoea
Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden
Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden
Cardiovascular Medicine - Collection 2017/6
